Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

NCT06216899 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT06216899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06216899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Lead sponsor
Seattle Children's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 11, 2024
Completion date
January 10, 2030
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease